Tolerogenic dendritic cells: Molecular and cellular mechanisms in transplantation

Journal of Leukocyte Biology

Volumn 95, Issue 1, 2014, Pages 53-69

  Švajger, Urban ^a   Rožman, Primož ^a  

^a BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

Author keywords

Allogeneic; Graft; Immunosuppressive; Inhibitory; Regulatory T cells; Tolerance

Indexed keywords

ARGINASE; CYTOKINE; FAS ANTIGEN; FAS LIGAND; HLA G ANTIGEN; ILT 2 PROTEIN; ILT 4 PROTEIN; INTERLEUKIN 10; PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL INTERACTION; CELL SURFACE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MEMORY T LYMPHOCYTE; MOLECULE; NONHUMAN; ORGAN TRANSPLANTATION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; ALLOGENEIC; ANIMAL; CELL COMMUNICATION; GENETICS; GRAFT; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE; INHIBITORY; METABOLISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TOLERANCE;

ALLOGENEIC; GRAFT; IMMUNOSUPPRESSIVE; INHIBITORY; REGULATORY T CELLS; TOLERANCE;

ANIMALS; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION IMMUNOLOGY;

EID: 84897018300     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0613336     Document Type: Review

References (216)

1. Steinman, R. M., Cohn, Z. A. (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142-1162.
2. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
3. Ohnmacht, C., Pullner, A., King, S. B., Drexler, I., Meier, S., Brocker, T., Voehringer, D. (2009) Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206, 549-559.
4. Bennett, C. L., Clausen, B. E. (2007) DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol. 28, 525-531.
5. Svajger, U., Obermajer, N., Jeras, M. (2010) Novel findings in druginduced dendritic cell tolerogenicity. Int. Rev. Immunol. 29, 574-607.
6. Steinman, R. M., Hawiger, D., Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
7. Cheever, M. A., Higano, C. S. (2011) Provenge (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin. Cancer Res. 17, 3520-3526.
8. Proietto, A. I., van Dommelen, S., Zhou, P., Rizzitelli, A., D'Amico, A., Steptoe, R. J., Naik, S. H., Lahoud, M. H., Liu, Y., Zheng, P., Shortman, K., Wu, L. (2008) Dendritic cells in the thymus contribute to Tregulatory cell induction. Proc. Natl. Acad. Sci. USA 105, 19869-19874.
9. Kyewski, B., Klein, L. (2006) A central role for central tolerance. Annu. Rev. Immunol. 24, 571-606.
10. Klein, L., Hinterberger, M., Wirnsberger, G., Kyewski, B. (2009) Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 9, 833-844.
11. Klein, L., Hinterberger, M., von Rohrscheidt, J., Aichinger, M. (2011) Autonomous versus dendritic cell-dependent contributions of medullary thymic epithelial cells to central tolerance. Trends Immunol. 32, 188-193.
12. Mathis, D., Benoist, C. (2004) Back to central tolerance. Immunity 20, 509-516.
13. Steinman, R. M., Hawiger, D., Liu, K., Bonifaz, L., Bonnyay, D., Mahnke, K., Iyoda, T., Ravetch, J., Dhodapkar, M., Inaba, K., Nussenz-weig, M. (2003) Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. N. Y. Acad. Sci. 987, 15-25.
14. Gad, M., Claesson, M. H., Pedersen, A. E. (2003) Dendritic cells in peripheral tolerance and immunity. APMIS 111, 766-775.
15. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., Nussenzweig, M. C. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779.
16. Idoyaga, J., Fiorese, C., Zbytnuik, L., Lubkin, A., Miller, J., Malissen, B., Mucida, D., Merad, M., Steinman, R. M. (2013) Specialized role of migratory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123, 844-854.
17. Schildknecht, A., Brauer, S., Brenner, C., Lahl, K., Schild, H., Sparwasser, T., Probst, H. C., van den Broek, M. (2010) FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc. Natl. Acad. Sci. USA 107, 199-203.
18. Lutz, M. B., Schuler, G. (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23, 445-449.
19. Huang, F.-P., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., MacPherson, G. G. (2000) A Discrete Subpopulation of Dendritic Cells Transports Apoptotic Intestinal Epithelial Cells to T Cell Areas of Mesenteric Lymph Nodes. J. Exp. Med. 191, 435-444.
20. Christensen, H. R., Frokiaer, H., Pestka, J. J. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168, 171-178.
21. Akbari, O., DeKruyff, R. H., Umetsu, D. T. (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2, 725-731.
22. Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N. A., Bogdan, C., Erb, K., Schuler, G., Lutz, M. B. (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15-21.
23. Vieira, P. L., de Jong, E. C., Wierenga, E. A., Kapsenberg, M. L., Kalinski, P. (2000) Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164, 4507-4512.
24. Yang, D. H., Kim, M. H., Hong, C. Y., Lee, Y. K., Jin, C. J., Pham, T. N., Ahn, J. S., Bae, W. K., Kim, Y. K., Chung, I. J., Kim, H. J., Kalinski, P., Lee, J. J. (2010) α-Type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Ann. Hematol. 89, 795-801.
25. Segura, E., Valladeau-Guilemond, J., Donnadieu, M. H., Sastre-Garau, X., Soumelis, V., Amigorena, S. (2012) Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp. Med. 209, 653-660.
26. Jang, M. H., Sougawa, N., Tanaka, T., Hirata, T., Hiroi, T., Tohya, K., Guo, Z., Umemoto, E., Ebisuno, Y., Yang, B. G., Seoh, J. Y., Lipp, M., Kiyono, H., Miyasaka, M. (2006) CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 176, 803-810.
27. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T., Henning, G., Forster, R. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279-288.
28. Adorini, L., Giarratana, N., Penna, G. (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16, 127-134.
29. Anderson, A. E., Swan, D. J., Sayers, B. L., Harry, R. A., Patterson, A. M., von Delwig, A., Robinson, J. H., Isaacs, J. D., Hilkens, C. M. (2009) LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J. Leukoc. Biol. 85, 243-250.
30. Riboldi, E., Musso, T., Moroni, E., Urbinati, C., Bernasconi, S., Rusnati, M., Adorini, L., Presta, M., Sozzani, S. (2005) Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J. Immunol. 175, 2788-2792.
31. Lan, Y. Y., Wang, Z., Raimondi, G., Wu, W., Colvin, B. L., de Creus, A., Thomson, A. W. (2006) "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce longterm organ allograft survival in combination with CTLA4-Ig. J. Immunol. 177, 5868-5877.
32. McGuirk, P., McCann, C., Mills, K. H. (2002) Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221-231.
33. Wakkach, A., Fournier, N., Brun, V., Breittmayer, J. P., Cottrez, F., Groux, H. (2003) Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18, 605-617.
34. Maldonado, R. A., von Andrian, U. H. (2010) How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108, 111-165.
35. Gregori, S. (2011) Dendritic cells in networks of immunological tolerance. Tissue Antigens 77, 89-99.
36. Wolfle, S. J., Strebovsky, J., Bartz, H., Sahr, A., Arnold, C., Kaiser, C., Dalpke, A. H., Heeg, K. (2011) PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur. J. Immunol. 41, 413-424.
37. Larmonier, N., Fraszczak, J., Lakomy, D., Bonnotte, B., Katsanis, E. (2010) Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunol. Immunother. 59, 1-11.
38. Tuettenberg, A., Huter, E., Hubo, M., Horn, J., Knop, J., Grimbacher, B., Kroczek, R. A., Stoll, S., Jonuleit, H. (2009) The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. J. Immunol. 182, 3349-3356.
39. Pallotta, M. T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M. L., Bianchi, R., Servillo, G., Brunacci, C., Calvitti, M., Bicciato, S., Mazza, E. M., Boon, L., Grassi, F., Fioretti, M. C., Fallarino, F., Puccetti, P., Grohmann, U. (2011) Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12, 870-878.
40. Trabanelli, S., Ocadlikova, D., Evangelisti, C., Parisi, S., Curti, A. (2011) Induction of regulatory T cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance. Curr. Med. Chem. 18, 2234-2239.
41. Chung, D. J., Rossi, M., Romano, E., Ghith, J., Yuan, J., Munn, D. H., Young, J. W. (2009) Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114, 555-563.
42. Cheng, C., Noorderloos, M., van Deel, E. D., Tempel, D., den Dekker, W., Wagtmans, K., Duncker, D. J., Soares, M. P., Laman, J. D., Duckers, H. J. (2010) Dendritic cell function in transplantation arteriosclerosis is regulated by heme oxygenase 1. Circ. Res 106, 1656-1666.
43. Moreau, A., Hill, M., Thebault, P., Deschamps, J. Y., Chiffoleau, E., Chauveau, C., Moullier, P., Anegon, I., Alliot-Licht, B., Cuturi, M. C. (2009) Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J. 23, 3070-3077.
44. Lutz, M. B., Suri, R. M., Niimi, M., Ogilvie, A. L., Kukutsch, N. A., Rossner, S., Schuler, G., Austyn, J. M. (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30, 1813-1822.
45. Taner, T., Hackstein, H., Wang, Z., Morelli, A. E., Thomson, A. W. (2005) Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 5, 228-236.
46. Fu, F., Li, Y., Qian, S., Lu, L., Chambers, F., Starzl, T. E., Fung, J. J., Thomson, A. W. (1996) Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62, 659-665.
47. Min, W. P., Gorczynski, R., Huang, X. Y., Kushida, M., Kim, P., Obataki, M., Lei, J., Suri, R. M., Cattral, M. S. (2000) Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J. Immunol. 164, 161-167.
48. Roelen, D. L., Schuurhuis, D. H., van den Boogaardt, D. E., Koekkoek, K., van Miert, P. P., van Schip, J. J., Laban, S., Rea, D., Melief, C. J., Offringa, R., Ossendorp, F., Claas, F. H. (2003) Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76, 1608-1615.
49. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J., Enk, A. H. (1997) Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159, 4772-4780.
50. Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J., Enk, A. H. (1999) Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93, 1634-1642.
51. Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., Enk, A. H. (2002) CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99, 2468-2476.
52. Stenger, E. O., Turnquist, H. R., Mapara, M. Y., Thomson, A. W. (2012) Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity. Blood 119, 5088-5103.
53. Morelli, A. E., Thomson, A. W. (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610-621.
54. Svajger, U., Obermajer, N., Jeras, M. (2010) Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology 129, 525-535.
55. Turnquist, H. R., Raimondi, G., Zahorchak, A. F., Fischer, R. T., Wang, Z., Thomson, A. W. (2007) Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigenspecific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol. 178, 7018-7031.
56. Buckland, M., Jago, C., Fazekesova, H., George, A., Lechler, R., Lombardi, G. (2006) Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. Int. Immunopharmacol. 6, 1895-1901.
57. Griffin, M. D., Lutz, W. H., Phan, V. A., Bachman, L. A., McKean, D. J., Kumar, R. (2000) Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 270, 701-708.
58. Belladonna, M. L., Volpi, C., Bianchi, R., Vacca, C., Orabona, C., Pallotta, M. T., Boon, L., Gizzi, S., Fioretti, M. C., Grohmann, U., Puccetti, P. (2008) Cutting edge: autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol. 181, 5194-5198.
59. Mimura, K., Kono, K., Takahashi, A., Kawaguchi, Y., Fujii, H. (2007) Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2. Cancer Immunol. Immunother. 56, 761-770.
60. Gonzalez-Rey, E., Ganea, D., Delgado, M. (2010) Neuropeptides: keeping the balance between pathogen immunity and immune tolerance. Curr. Opin. Pharmacol. 10, 473-481.
61. Svajger, U., Vidmar, A., Jeras, M. (2008) Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4. Int. Immunopharmacol. 8, 997-1005.
62. Szabo, G., Gavala, C., Mandrekar, P. (2001) Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J. Investig. Med. 49, 442-449.
63. Rutella, S., Danese, S., Leone, G. (2006) Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108, 1435-1440.
64. Sun, C. M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., Belkaid, Y. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785.
65. Iwasaki, A., Kelsall, B. L. (1999) Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229-239.
66. Streilein, J. W. (2003) Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 74, 179-185.
67. Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C. F., Hauben, E., Roncarolo, M. G. (2010) Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116, 935-944.
68. Papenfuss, T. L., Powell, N. D., McClain, M. A., Bedarf, A., Singh, A., Gienapp, I. E., Shawler, T., Whitacre, C. C. (2011) Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J. Immunol. 186, 3346-3355.
69. Liu, Y. J. (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306.
70. Young, L. J., Wilson, N. S., Schnorrer, P., Proietto, A., ten Broeke, T., Matsuki, Y., Mount, A. M., Belz, G. T., O'Keeffe, M., Ohmura-Hoshino, M., Ishido, S., Stoorvogel, W., Heath, W. R., Shortman, K., Villadangos, J. A. (2008) Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9, 1244-1252.
71. Rogers, N. M., Isenberg, J. S., Thomson, A. W. (2013) Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance? Am. J. Transplant. 13, 1125-1133.
72. Matta, B. M., Raimondi, G., Rosborough, B. R., Sumpter, T. L., Thomson, A. W. (2012) IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells. J. Immunol. 188, 5227-5237.
73. Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P. A., Iwashima, M., Munn, D. H. (2003) Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171, 1652-1655.
74. Fallarino, F., Asselin-Paturel, C., Vacca, C., Bianchi, R., Gizzi, S., Fioretti, M. C., Trinchieri, G., Grohmann, U., Puccetti, P. (2004) Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173, 3748-3754.
75. Abe, M., Wang, Z., de Creus, A., Thomson, A. W. (2005) Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5, 1808-1819.
76. Bjorck, P., Coates, P. T., Wang, Z., Duncan, F. J., Thomson, A. W. (2005) Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody. J. Heart Lung Transplant. 24, 1118-1120.
77. Fugier-Vivier, I. J., Rezzoug, F., Huang, Y., Graul-Layman, A. J., Schanie, C. L., Xu, H., Chilton, P. M., Ildstad, S. T. (2005) Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201, 373-383.
78. Huang, Y., Bozulic, L. D., Miller, T., Xu, H., Hussain, L. R., Ildstad, S. T. (2011) CD8&α;+ plasmacytoid precursor DCs induce antigenspecific regulatory T cells that enhance HSC engraftment in vivo. Blood 117, 2494-2505.
79. Lu, Y., Giver, C. R., Sharma, A., Li, J. M., Darlak, K. A., Owens, L. M., Roback, J. D., Galipeau, J., Waller, E. K. (2012) IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity. Blood 119, 1075-1085.
80. O'Connell, P. J., Li, W., Wang, Z., Specht, S. M., Logar, A. J., Thomson, A. W. (2002) Immature and mature CD8α+ dendritic cells prolong the survival of vascularized heart allografts. J. Immunol. 168, 143-154.
81. Qiu, C. H., Miyake, Y., Kaise, H., Kitamura, H., Ohara, O., Tanaka, M. (2009) Novel subset of CD8{α}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J. Immunol. 182, 4127-4136.
82. Ochando, J. C., Homma, C., Yang, Y., Hidalgo, A., Garin, A., Tacke, F., Angeli, V., Li, Y., Boros, P., Ding, Y., Jessberger, R., Trinchieri, G., Lira, S. A., Randolph, G. J., Bromberg, J. S. (2006) Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7, 652-662.
83. De Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C., Lambrecht, B. N. (2004) Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89-98.
84. Hadeiba, H., Sato, T., Habtezion, A., Oderup, C., Pan, J., Butcher, E. C. (2008) CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9, 1253-1260.
85. Tokita, D., Mazariegos, G. V., Zahorchak, A. F., Chien, N., Abe, M., Raimondi, G., Thomson, A. W. (2008) High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 85, 369-377.
86. Mazariegos, G. V., Zahorchak, A. F., Reyes, J., Ostrowski, L., Flynn, B., Zeevi, A., Thomson, A. W. (2003) Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am. J. Transplant. 3, 689-696.
87. Chen, Z. M., O'Shaughnessy, M. J., Gramaglia, I., Panoskaltsis-Mortari, A., Murphy, W. J., Narula, S., Roncarolo, M. G., Blazar, B. R. (2003) IL-10 and TGF-β induce alloreactive CD4+CD25-T cells to acquire regulatory cell function. Blood 101, 5076-5083.
88. Battaglia, M., Stabilini, A., Draghici, E., Gregori, S., Mocchetti, C., Bonifacio, E., Roncarolo, M. G. (2006) Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55, 40-49.
89. Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., Roncarolo, M. G. (2005) Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105, 1162-1169.
90. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., Levings, M. K. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50.
91. De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., de Vries, J. E. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
92. Couper, K. N., Blount, D. G., Riley, E. M. (2008) IL-10: the master regulator of immunity to infection. J. Immunol. 180, 5771-5777.
93. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
94. Cook, C. H., Bickerstaff, A. A., Wang, J. J., Nadasdy, T., Della Pelle, P., Colvin, R. B., Orosz, C. G. (2008) Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO. J. Immunol. 180, 3103-3112.
95. Chen, W., Jin, W., Hardegen, N., Lei, K-j., Li, L., Marinos, N., McGrady, G., Wahl, S. M. (2003) Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25-regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886.
96. Curti, A., Trabanelli, S., Salvestrini, V., Baccarani, M., Lemoli, R. M. (2009) The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood 113, 2394-2401.
97. Blazar, B. R., Carreno, B. M., Panoskaltsis-Mortari, A., Carter, L., Iwai, Y., Yagita, H., Nishimura, H., Taylor, P. A. (2003) Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism. J. Immunol. 171, 1272-1277.
98. Hill, M., Thebault, P., Segovia, M., Louvet, C., Beriou, G., Tilly, G., Merieau, E., Anegon, I., Chiffoleau, E., Cuturi, M. C. (2011) Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon-γ and Epstein-Barr virus-induced gene 3. Am. J. Transplant. 11, 2036-2045.
99. Yoshida, H., Miyazaki, Y. (2008) Regulation of immune responses by interleukin-27. Immunol. Rev. 226, 234-247.
100. Collison, L. W., Vignali, D. A. (2008) Interleukin-35: odd one out or part of the family? Immunol. Rev. 226, 248-262.
101. Sawitzki, B., Kingsley, C. I., Oliveira, V., Karim, M., Herber, M., Wood, K. J. (2005) IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201, 1925-1935.
102. Svajger, U., Obermajer, N., Jeras, M. (2013) IFN-γ-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J. Leukoc. Biol. doi: 10.1189/jlb.1112589. [Epub ahead of print].
103. Le Texier, L., Thebault, P., Carvalho-Gaspar, M., Vignard, V., Merieau, E., Usal, C., Cuturi, M. C., Wood, K. J., Chiffoleau, E. (2012) Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation. Transplantation 94, 226-233.
104. Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., Weiner, H. L. (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389.
105. Fitzgerald, D. C., Zhang, G. X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J., Gran, B., Ciric, B., Rostami, A. (2007) Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372-1379.
106. Freitas do Rosario, A. P., Lamb, T., Spence, P., Stephens, R., Lang, A., Roers, A., Muller, W., O'Garra, A., Langhorne, J. (2012) IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188, 1178-1190.
107. Li, M., Zhang, X., Zheng, X., Lian, D., Zhang, Z-X., Sun, H., Suzuki, M., Vladau, C., Huang, X., Xia, X., Zhong, R., Garcia, B., Min, W-P. (2008) Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance. Int. Immunol. 20, 285-293.
108. Min, W. P., Zhou, D., Ichim, T. E., Strejan, G. H., Xia, X., Yang, J., Huang, X., Garcia, B., White, D., Dutartre, P., Jevnikar, A. M., Zhong, R. (2003) Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J. Immunol. 170, 1304-1312.
109. Reddy, P., Sun, Y., Toubai, T., Duran-Struuck, R., Clouthier, S. G., Weisiger, E., Maeda, Y., Tawara, I., Krijanovski, O., Gatza, E., Liu, C., Malter, C., Mascagni, P., Dinarello, C. A., Ferrara, J. L. (2008) Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J. Clin. Invest. 118, 2562-2573.
110. Liu, H., Liu, L., Fletcher, B. S., Visner, G. A. (2006) Sleeping Beautybased gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. FASEB J. 20, 2384-2386.
111. Liu, H., Liu, L., Fletcher, B. S., Visner, G. A. (2006) Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury. Am. J. Respir. Crit. Care Med. 173, 566-572.
112. Li, J., Meinhardt, A., Roehrich, M. E., Golshayan, D., Dudler, J., Pagnotta, M., Trucco, M., Vassalli, G. (2007) Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival. Am. J. Physiol. Heart Circ. Physiol. 293, H3415-H3423.
113. Lin, Y. C., Chen, C. L., Nakano, T., Goto, S., Kao, Y. H., Hsu, L. W., Lai, C. Y., Jawan, B., Cheng, Y. F., Tateno, C., Yoshizato, K. (2008) Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance. J. Gastroenterol. Hepatol. 23, e243-e250.
114. Li, Y., Tredget, E. E., Ghaffari, A., Lin, X., Kilani, R. T., Ghahary, A. (2006) Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J. Invest. Dermatol. 126, 128-136.
115. Gelman, A. E., Okazaki, M., Lai, J., Kornfeld, C. G., Kreisel, F. H., Richardson, S. B., Sugimoto, S., Tietjens, J. R., Patterson, G. A., Krupnick, A. S., Kreisel, D. (2008) CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J. Immunol. 180, 4754-4762.
116. Liu, H., Liu, L., Liu, K., Bizargity, P., Hancock, W. W., Visner, G. A. (2009) Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression. J. Immunol. 183, 1022-1031.
117. Soares, M. P., Bach, F. H. (2009) Heme oxygenase-1: from biology to therapeutic potential. Trends Mol. Med. 15, 50-58.
118. Chauveau, C., Remy, S., Royer, P. J., Hill, M., Tanguy-Royer, S., Hubert, F. X., Tesson, L., Brion, R., Beriou, G., Gregoire, M., Josien, R., Cuturi, M. C., Anegon, I. (2005) Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106, 1694-1702.
119. Brusko, T. M., Wasserfall, C. H., Agarwal, A., Kapturczak, M. H., Atkinson, M. A. (2005) An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J. Immunol. 174, 5181-5186.
120. Yamashita, K., Ollinger, R., McDaid, J., Sakahama, H., Wang, H., Tyagi, S., Csizmadia, E., Smith, N. R., Soares, M. P., Bach, F. H. (2006) Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J. 20, 776-778.
121. Chabannes, D., Hill, M., Merieau, E., Rossignol, J., Brion, R., Soulillou, J. P., Anegon, I., Cuturi, M. C. (2007) A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110, 3691-3694.
122. Vlad, G., Chang, C. C., Colovai, A. I., Berloco, P., Cortesini, R., Suciu-Foca, N. (2009) Immunoglobulin-like transcript 3: a crucial regulator of dendritic cell function. Hum. Immunol. 70, 340-344.
123. Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D., Suciu-Foca, N. (2003) High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11, 245-258.
124. Vlad, G., Piazza, F., Colovai, A., Cortesini, R., Della Pietra, F., Suciu-Foca, N., Manavalan, J. S. (2003) Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum. Immunol. 64, 483-489.
125. Ristich, V., Liang, S., Zhang, W., Wu, J., Horuzsko, A. (2005) Tolerization of dendritic cells by HLA-G. Eur. J. Immunol. 35, 1133-1142.
126. Brenk, M., Scheler, M., Koch, S., Neumann, J., Takikawa, O., Hacker, G., Bieber, T., von Bubnoff, D. (2009) Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. J. Immunol. 183, 145-154.
127. Adorini, L., Penna, G. (2009) Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol. 70, 345-352.
128. Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., Suciu-Foca, N. (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237-243.
129. Amodio, G., Mugione, A., Sanchez, A. M., Vigano, P., Candiani, M., Somigliana, E., Roncarolo, M. G., Panina-Bordignon, P., Gregori, S. (2013) HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Hum. Immunol. 74, 406-411.
130. Carosella, E. D., Gregori, S., LeMaoult, J. (2011) The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood 118, 6499-6505.
131. Ma, Y., Shurin, G. V., Gutkin, D. W., Shurin, M. R. (2012) Tumor associated regulatory dendritic cells. Semin. Cancer Biol. 22, 298-306.
132. Huang, J., Burke, P., Yang, Y., Seiss, K., Beamon, J., Cung, T., Toth, I., Pereyra, F., Lichterfeld, M., Yu, X. G. (2010) Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2. J. Virol. 84, 10784-10791.
133. Castellaneta, A., Mazariegos, G. V., Nayyar, N., Zeevi, A., Thomson, A. W. (2011) HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance. Transplantation 91, 1132-1140.
134. Naji, A., Durrbach, A., Carosella, E. D., Rouas-Freiss, N. (2007) Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways. Hum. Immunol. 68, 233-239.
135. Naji, A., Le Rond, S., Durrbach, A., Krawice-Radanne, I., Creput, C., Daouya, M., Caumartin, J., LeMaoult, J., Carosella, E. D., Rouas-Freiss, N. (2007) CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 110, 3936-3948.
136. Baştürk, B., Karakayali{dotless}, F., Emiroǧlu, R., Sözer, O., Haberal, A., Bal, D., Haberal, M. (2006) Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant. Proc. 38, 571-574.
137. Creput, C., Le Friec, G., Bahri, R., Amiot, L., Charpentier, B., Carosella, E., Rouas-Freiss, N., Durrbach, A. (2003) Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum. Immunol. 64, 1033-1038.
138. Luque, J., Torres, M. I., Aumente, M. D., Marin, J., Garcia-Jurado, G., Gonzalez, R., Pascual, D., Guerra, N., Lopez-Rubio, F., Alvarez-Lopez, M. R., Arizon, J. M., Pena, J. (2006) Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum. Immunol. 67, 257-263.
139. Brugiere, O., Thabut, G., Pretolani, M., Krawice-Radanne, I., Dill, C., Herbreteau, A., Poras, I., Moreau, P., Colombat, M., Danel, C., Dehoux, M., Fournier, M., Carosella, E. D., Rouas-Freiss, N. (2009) Immunohistochemical study of HLA-G expression in lung transplant recipients. Am. J. Transplant. 9, 1427-1438.
140. Brugière, O., Thabut, G., Krawice, I., Carosella, E., Rouas-Freiss, N. (2013) Role of HLA-G expression as a predictive marker of a low risk of bronchiolitis obliterans syndrome in lung transplant Rrecipients: a 3-year prospective study. J. Heart Lung Transplant. 32, S168.
141. Bahri, R., Naji, A., Menier, C., Charpentier, B., Carosella, E. D., Rouas-Freiss, N., Durrbach, A. (2009) Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. J. Immunol. 183, 7054-7062.
142. Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., Freeman, G. J. (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170, 1257-1266.
143. Nishimura, H., Honjo, T. (2001) PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22, 265-268.
144. Nishimura, H., Nose, M., Hiai, H., Minato, N., Honjo, T. (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151.
145. Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., Bluestone, J. A. (2009) Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 10, 1185-1192.
146. Kitazawa, Y., Fujino, M., Wang, Q., Kimura, H., Azuma, M., Kubo, M., Abe, R., Li, X. K. (2007) Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation 83, 774-782.
147. Amarnath, S., Costanzo, C. M., Mariotti, J., Ullman, J. L., Telford, W. G., Kapoor, V., Riley, J. L., Levine, B. L., June, C. H., Fong, T., Warner, N. L., Fowler, D. H. (2010) Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol. 8, e1000302.
148. Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., Sharpe, A. H. (2006) Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203, 883-895.
149. Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., Kroczek, R. A. (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263-266.
150. Ito, T., Yang, M., Wang, Y. H., Lande, R., Gregorio, J., Perng, O. A., Qin, X. F., Liu, Y. J., Gilliet, M. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105-115.
151. Chambers, C. A. (2001) The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol. 22, 217-223.
152. Guillonneau, C., Aubry, V., Renaudin, K., Seveno, C., Usal, C., Tezuka, K., Anegon, I. (2005) Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation 80, 255-263.
153. Maher, S., Toomey, D., Condron, C., Bouchier-Hayes, D. (2002) Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol. Cell Biol. 80, 131-137.
154. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M., Krammer, P. H. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
155. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., Dixit, V. M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
156. Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355-365.
157. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
158. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., Ferguson, T. A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
159. Suss, G., Shortman, K. (1996) A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183, 1789-1796.
160. Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J. P., Fernandez, M., Chastang, C. (1997) Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 337, 373-381.
161. Naderi, N., Moazzeni, S. M., Pourfathollah, A. A., Alimoghaddam, K. (2011) High expression of Fas ligand on cord blood dendritic cells: a possible immunoregulatory mechanism after cord blood transplantation. Transplant. Proc. 43, 3913-3919.
162. George, J. F., Sweeney, S. D., Kirklin, J. K., Simpson, E. M., Goldstein, D. R., Thomas, J. M. (1998) An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat. Med. 4, 333-335.
163. Terness, P., Kallikourdis, M., Betz, A. G., Rabinovich, G. A., Saito, S., Clark, D. A. (2007) Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am. J. Reprod. Immunol. 58, 238-254.
164. Mellor, A. L., Munn, D. H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774.
165. Hainz, U., Jurgens, B., Heitger, A. (2007) The role of indoleamine 2,3-dioxygenase in transplantation. Transpl. Int. 20, 118-127.
166. Mitchell, P., Afzali, B., Lombardi, G., Lechler, R. I. (2009) The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr. Opin. Organ Transplant. 14, 326-331.
167. Zhang, J. (2007) Yin and yang interplay of IFN-γ in inflammation and autoimmune disease. J. Clin. Invest. 117, 871-873.
168. Adams, A. B., Williams, M. A., Jones, T. R., Shirasugi, N., Durham, M. M., Kaech, S. M., Wherry, E. J., Onami, T., Lanier, J. G., Kokko, K. E., Pearson, T. C., Ahmed, R., Larsen, C. P. (2003) Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111, 1887-1895.
169. Valujskikh, A., Lantz, O., Celli, S., Matzinger, P., Heeger, P. S. (2002) Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3, 844-851.
170. Colonna, M., Nakajima, H., Navarro, F., Lopez-Botet, M. (1999) A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66, 375-381.
171. Colonna, M., Nakajima, H., Cella, M. (2000) A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin. Immunol. 12, 121-127.
172. Munitz, A. (2010) Inhibitory receptors on myeloid cells: new targets for therapy? Pharmacol. Ther. 125, 128-137.
173. Menier, C., Rouas-Freiss, N., Favier, B., LeMaoult, J., Moreau, P., Carosella, E. D. (2010) Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 75, 201-206.
174. Liang, S., Horuzsko, A. (2003) Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum. Immunol. 64, 1025-1032.
175. Le Friec, G., Laupeze, B., Fardel, O., Sebti, Y., Pangault, C., Guilloux, V., Beauplet, A., Fauchet, R., Amiot, L. (2003) Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum. Immunol. 64, 752-761.
176. Liang, S., Baibakov, B., Horuzsko, A. (2002) HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur. J. Immunol. 32, 2418-2426.
177. Zarkhin, V., Talisetti, A., Li, L., Wozniak, L. J., McDiarmid, S. V., Cox, K., Esquivel, C., Sarwal, M. M. (2010) Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation 90, 1000-1005.
178. Kabelitz, D., Pohl, T., Pechhold, K. (1993) Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14, 338-339.
179. Liu, Q., Zhang, C., Sun, A., Zheng, Y., Wang, L., Cao, X. (2009) Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I. J. Immunol. 182, 6207-6216.
180. Yagnik, G. P., Takahashi, Y., Tsoulfas, G., Reid, K., Murase, N., Geller, D. A. (2002) Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 36, 573-581.
181. Highfill, S. L., Rodriguez, P. C., Zhou, Q., Goetz, C. A., Koehn, B. H., Veenstra, R., Taylor, P. A., Panoskaltsis-Mortari, A., Serody, J. S., Munn, D. H., Tolar, J., Ochoa, A. C., Blazar, B. R. (2010) Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116, 5738-5747.
182. Ochoa, A. C., Zea, A. H., Hernandez, C., Rodriguez, P. C. (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13, 721s-726s.
183. Sakaguchi, S., Miyara, M., Costantino, C. M., Hafler, D. A. (2010) FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490-500.
184. Josefowicz, S. Z., Lu, L. F., Rudensky, A. Y. (2012) Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564.
185. Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R. I., Cecchini, D., Aloisi, T., Perruccio, K., Ruggeri, L., Balucani, C., Pierini, A., Sportoletti, P., Aristei, C., Falini, B., Reisner, Y., Velardi, A., Aversa, F., Martelli, M. F. (2011) Tregs prevent GVHD and promote immune reconstitution in HLAhaploidentical transplantation. Blood 117, 3921-3928.
186. Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K., Steinman, R. M. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247.
187. Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., Dhodapkar, K. M. (2006) Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokinematured DCs in myeloma patients. Blood 108, 2655-2661.
188. Luo, X., Tarbell, K. V., Yang, H., Pothoven, K., Bailey, S. L., Ding, R., Steinman, R. M., Suthanthiran, M. (2007) Dendritic cells with TGF-β1 differentiate naive CD4+CD25+ T cells into islet-protective Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104, 2821-2826.
189. Onishi, Y., Fehervari, Z., Yamaguchi, T., Sakaguchi, S. (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105, 10113-10118.
190. Oldenhove, G., de Heusch, M., Urbain-Vansanten, G., Urbain, J., Maliszewski, C., Leo, O., Moser, M. (2003) CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 198, 259-266.
191. Brinster, C., Shevach, E. M. (2005) Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function. J. Immunol. 175, 7332-7340.
192. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., Sakaguchi, S. (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
193. Read, S., Malmstrom, V., Powrie, F. (2000) Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302.
194. Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., Bluestone, J. A. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440.
195. Tran, D. Q., Shevach, E. M. (2009) Therapeutic potential of FOXP3(+) regulatory T cells and their interactions with dendritic cells. Hum. Immunol. 70, 294-299.
196. Sela, U., Olds, P., Park, A., Schlesinger, S. J., Steinman, R. M. (2011) Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J. Exp. Med. 208, 2489-2496.
197. Yang, H., Cheng, E. Y., Sharma, V. K., Lagman, M., Chang, C., Song, P., Ding, R., Muthukumar, T., Suthanthiran, M. (2012) Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells. Transplantation 93, 580-588.
198. Serafini, G., Andreani, M., Testi, M., Battarra, M., Bontadini, A., Biral, E., Fleischhauer, K., Marktel, S., Lucarelli, G., Roncarolo, M. G., Bacchetta, R. (2009) Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia. Haematologica 94, 1415-1426.
199. Gagliani, N., Jofra, T., Stabilini, A., Valle, A., Atkinson, M., Roncarolo, M. G., Battaglia, M. (2010) Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes 59, 433-439.
200. Unger, W. W., Laban, S., Kleijwegt, F. S., van der Slik, A. R., Roep, B. O. (2009) Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39, 3147-3159.
201. Kaech, S. M., Wherry, E. J., Ahmed, R. (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251-262.
202. Wang, X. N., Proctor, S. J., Dickinson, A. M. (1996) Frequency analysis of recipient-reactive helper and cytotoxic T lymphocyte precursors using a combined single limiting dilution assay. Transpl. Immunol. 4, 247-251.
203. Ford, W. L., Atkins, R. C. (1973) The proportion of lymphocytes capable of recognizing strong transplantation antigens in vivo. Adv. Exp. Med. Biol. 29, 255-262.
204. Lombardi, G., Sidhu, S., Daly, M., Batchelor, J. R., Makgoba, W., Lechler, R. I. (1990) Are primary alloresponses truly primary? Int. Immunol. 2, 9-13.
205. McFarland, R. D., Douek, D. C., Koup, R. A., Picker, L. J. (2000) Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. USA 97, 4215-4220.
206. Bingaman, A. W., Farber, D. L. (2004) Memory T cells in transplantation: generation, function, and potential role in rejection. Am. J. Transplant. 4, 846-852.
207. Kaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., Lehmann, P. V. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366, 69-72.
208. DiLorenzo, T. P., Lieberman, S. M., Takaki, T., Honda, S., Chapman, H. D., Santamaria, P., Serreze, D. V., Nathenson, S. G. (2002) During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities. Clin. Immunol. 105, 332-341.
209. Yang, J., Brook, M. O., Carvalho-Gaspar, M., Zhang, J., Ramon, H. E., Sayegh, M. H., Wood, K. J., Turka, L. A., Jones, N. D. (2007) Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl. Acad. Sci. USA 104, 19954-19959.
210. London, C. A., Lodge, M. P., Abbas, A. K. (2000) Functional responses and costimulator dependence of memory CD4+ T cells. J. Immunol. 164, 265-272.
211. Croft, M., Bradley, L. M., Swain, S. L. (1994) Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152, 2675-2685.
212. Kenna, T. J., Thomas, R., Steptoe, R. J. (2008) Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses. Blood 111, 2091-2100.
213. Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., Ahmed, R. (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911-4927.
214. Nasreen, M., Waldie, T. M., Dixon, C. M., Steptoe, R. J. (2010) Steadystate antigen-expressing dendritic cells terminate CD4+ memory T-cell responses. Eur. J. Immunol. 40, 2016-2025.
215. Doan, T., McNally, A., Thomas, R., Steptoe, R. J. (2009) Steady-state dendritic cells continuously inactivate T cells that escape thymic negative selection. Immunol. Cell Biol. 87, 615-622.
216. Torres-Aguilar, H., Aguilar-Ruiz, S. R., Gonzalez-Perez, G., Munguia, R., Bajana, S., Meraz-Rios, M. A., Sanchez-Torres, C. (2010) Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J. Immunol. 184, 1765-1775.